Evaluation of laboratory effectiveness of clopidogrel after elective endovascular procedures in patients with the history of the new coronavirus infection (COVID-19)
Aim. To evaluate the impact of antiplatelet agent clopidogrel on the aggregation platelet activity in patients with the history of the new coronavirus infection (COVID-19). Materials and methods. The impact of clopidogrel on platelet aggregation was studied in 47 patients with coronary heart disease...
Saved in:
Main Authors: | Natalia V. Kuchkina (Author), Nino V. Tsereteli (Author), Irina E. Chernysheva (Author), Elena I. Vorobyeva (Author), Irina V. Zubkova (Author), Sergey P. Semitko (Author), David G. Iosseliani (Author), Viktor V. Fomin (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Verified case of classical takotsubo syndrome. Case report
by: Sergey P. Semitko, et al.
Published: (2023) -
Anatomy of the coronary arteries and localization of coronary atherosclerosis in siblings with coronary heart disease
by: Imomali H. Kamolov, et al.
Published: (2022) -
Pain assessment and management in patients undergoing endovascular procedures in the catheterization laboratory
by: Thamires de Souza Hilário, et al. -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)